- Home
- WAVE vs CVKD Comparison
WAVE vs CVKD Comparison
Compare WAVE & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- CVKD
- Stock Information
- Founded
- WAVE 2011
- CVKD 2022
- Country
- WAVE Israel
- CVKD United States
- Employees
- WAVE N/A
- CVKD N/A
- Industry
- WAVE Electric Utilities: Central
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- WAVE Utilities
- CVKD Health Care
- Exchange
- WAVE Nasdaq
- CVKD Nasdaq
- Market Cap
- WAVE 35.0M
- CVKD 33.7M
- IPO Year
- WAVE 2021
- CVKD 2023
- Fundamental
- Price
- WAVE $6.63
- CVKD $14.71
- Analyst Decision
- WAVE Strong Buy
- CVKD Strong Buy
- Analyst Count
- WAVE 1
- CVKD 1
- Target Price
- WAVE $15.00
- CVKD $32.00
- AVG Volume (30 Days)
- WAVE 28.5K
- CVKD 21.0K
- Earning Date
- WAVE 05-08-2025
- CVKD 05-08-2025
- Dividend Yield
- WAVE N/A
- CVKD N/A
- EPS Growth
- WAVE N/A
- CVKD N/A
- EPS
- WAVE N/A
- CVKD N/A
- Revenue
- WAVE $168,000.00
- CVKD N/A
- Revenue This Year
- WAVE $325.00
- CVKD N/A
- Revenue Next Year
- WAVE $85.71
- CVKD N/A
- P/E Ratio
- WAVE N/A
- CVKD N/A
- Revenue Growth
- WAVE N/A
- CVKD N/A
- 52 Week Low
- WAVE $2.20
- CVKD $5.70
- 52 Week High
- WAVE $17.63
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- WAVE 52.92
- CVKD 41.38
- Support Level
- WAVE $5.90
- CVKD $15.29
- Resistance Level
- WAVE $6.79
- CVKD $16.50
- Average True Range (ATR)
- WAVE 0.47
- CVKD 0.76
- MACD
- WAVE 0.08
- CVKD -0.05
- Stochastic Oscillator
- WAVE 71.80
- CVKD 11.09
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.